Cargando…

Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?

Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled...

Descripción completa

Detalles Bibliográficos
Autores principales: Bol, Karin, Haeck, Joost C., Groen, Harald C., Niessen, Wiro J., Bernsen, Monique R., de Jong, Marion, Veenland, Jifke F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792933/
https://www.ncbi.nlm.nih.gov/pubmed/24116203
http://dx.doi.org/10.1371/journal.pone.0077076
_version_ 1782286902149251072
author Bol, Karin
Haeck, Joost C.
Groen, Harald C.
Niessen, Wiro J.
Bernsen, Monique R.
de Jong, Marion
Veenland, Jifke F.
author_facet Bol, Karin
Haeck, Joost C.
Groen, Harald C.
Niessen, Wiro J.
Bernsen, Monique R.
de Jong, Marion
Veenland, Jifke F.
author_sort Bol, Karin
collection PubMed
description Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled peptides can be visualized in a neuroendocrine tumor model overexpressing somatostatin receptors. A heterogeneous peptide uptake is often observed in these tumors. We hypothesized that peptide distribution in the tumor is spatially related to tumor perfusion, vessel density and permeability, as imaged and quantified by DCE-MRI in a neuroendocrine tumor model. Four subcutaneous CA20948 tumor-bearing Lewis rats were injected with the somatostatin-analog (111)In-DTPA-Octreotide (50 MBq). SPECT-CT and MRI scans were acquired and MRI was spatially registered to SPECT-CT. DCE-MRI was analyzed using semi-quantitative and quantitative methods. Correlation between SPECT and DCE-MRI was investigated with 1) Spearman’s rank correlation coefficient; 2) SPECT uptake values grouped into deciles with corresponding median DCE-MRI parametric values and vice versa; and 3) linear regression analysis for median parameter values in combined datasets. In all tumors, areas with low peptide uptake correlated with low perfusion/density/ /permeability for all DCE-MRI-derived parameters. Combining all datasets, highest linear regression was found between peptide uptake and semi-quantitative parameters (R(2)>0.7). The average correlation coefficient between SPECT and DCE-MRI-derived parameters ranged from 0.52-0.56 (p<0.05) for parameters primarily associated with exchange between blood and extracellular extravascular space. For these parameters a linear relation with peptide uptake was observed. In conclusion, the ‘exchange-related’ DCE-MRI-derived parameters seemed to predict peptide uptake better than the ‘contrast amount- related’ parameters. Consequently, fast and efficient diffusion through the vessel wall into tissue is an important factor for peptide delivery. DCE-MRI helps to elucidate the relation between vascular characteristics, peptide delivery and treatment efficacy, and may form a basis to predict targeting efficiency.
format Online
Article
Text
id pubmed-3792933
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37929332013-10-10 Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model? Bol, Karin Haeck, Joost C. Groen, Harald C. Niessen, Wiro J. Bernsen, Monique R. de Jong, Marion Veenland, Jifke F. PLoS One Research Article Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled peptides can be visualized in a neuroendocrine tumor model overexpressing somatostatin receptors. A heterogeneous peptide uptake is often observed in these tumors. We hypothesized that peptide distribution in the tumor is spatially related to tumor perfusion, vessel density and permeability, as imaged and quantified by DCE-MRI in a neuroendocrine tumor model. Four subcutaneous CA20948 tumor-bearing Lewis rats were injected with the somatostatin-analog (111)In-DTPA-Octreotide (50 MBq). SPECT-CT and MRI scans were acquired and MRI was spatially registered to SPECT-CT. DCE-MRI was analyzed using semi-quantitative and quantitative methods. Correlation between SPECT and DCE-MRI was investigated with 1) Spearman’s rank correlation coefficient; 2) SPECT uptake values grouped into deciles with corresponding median DCE-MRI parametric values and vice versa; and 3) linear regression analysis for median parameter values in combined datasets. In all tumors, areas with low peptide uptake correlated with low perfusion/density/ /permeability for all DCE-MRI-derived parameters. Combining all datasets, highest linear regression was found between peptide uptake and semi-quantitative parameters (R(2)>0.7). The average correlation coefficient between SPECT and DCE-MRI-derived parameters ranged from 0.52-0.56 (p<0.05) for parameters primarily associated with exchange between blood and extracellular extravascular space. For these parameters a linear relation with peptide uptake was observed. In conclusion, the ‘exchange-related’ DCE-MRI-derived parameters seemed to predict peptide uptake better than the ‘contrast amount- related’ parameters. Consequently, fast and efficient diffusion through the vessel wall into tissue is an important factor for peptide delivery. DCE-MRI helps to elucidate the relation between vascular characteristics, peptide delivery and treatment efficacy, and may form a basis to predict targeting efficiency. Public Library of Science 2013-10-08 /pmc/articles/PMC3792933/ /pubmed/24116203 http://dx.doi.org/10.1371/journal.pone.0077076 Text en © 2013 Bol et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bol, Karin
Haeck, Joost C.
Groen, Harald C.
Niessen, Wiro J.
Bernsen, Monique R.
de Jong, Marion
Veenland, Jifke F.
Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title_full Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title_fullStr Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title_full_unstemmed Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title_short Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?
title_sort can dce-mri explain the heterogeneity in radiopeptide uptake imaged by spect in a pancreatic neuroendocrine tumor model?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792933/
https://www.ncbi.nlm.nih.gov/pubmed/24116203
http://dx.doi.org/10.1371/journal.pone.0077076
work_keys_str_mv AT bolkarin candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT haeckjoostc candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT groenharaldc candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT niessenwiroj candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT bernsenmoniquer candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT dejongmarion candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel
AT veenlandjifkef candcemriexplaintheheterogeneityinradiopeptideuptakeimagedbyspectinapancreaticneuroendocrinetumormodel